We tested MAP and HR in TM1, TM2, and TM3 as secondary outcomes, and found slight decreases in MAP or HR from TM1 to TM2 and TM3, but the differences did not reach statistical significance.
← all excerpts
Association of the lncRNA-GAS5 promoter region rs145204276 polymorphism with sevoflurane maintenance anesthesia outcomes on patients undergoing laparoscopic cholecystectomy.
1
—
—